Anzeige
Mehr »
Samstag, 13.09.2025 - Börsentäglich über 12.000 News
Investment Idee: Einsteigen bevor sich die Schleuse öffnet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrPayPal vs. StoneCo: Which Fintech Stock Offers Greater Upside Now?
FrRGTI Strengthens Global Ties in Quantum Push: Time to Buy or Hold?
FrHims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
FrCopa Holdings' August 2025 Traffic Improves Year Over Year
FrWill Amazon Partnership Help Netflix Double Ad Revenue Targets?
FrBaker Hughes Wins Key Contract to Support Sakarya Gas Field Phase 3
FrFrom Polaris to Vision AI: Is SoundHound Building a Moat in GenAI?
FrIs Alibaba's AI Revolution Worth the Risk for Growth Investors Now?
FrWhy ExxonMobil Can Weather Market Uncertainty Better Than Peers
FrPetrobras Awards Vallourec $1B Multi-Year Contract for Offshore Growth
FrEnterprise Products' $6B Capital Projects Secure Incremental Cash Flows
FrCan Primoris's Data Center Strategy Power a New Phase of Growth?
FrSAP Boosts AI-Driven Recruiting Innovation With SmartRecruiters Buyout
FrFAF Boosts Shareholders' Value Via Dividend Hike, Shares Rise
FrElevance Health Shrinks to Grow Stronger: From Part D to Plan B?
FrCiena's Stock Skyrockets 143% in 12 Months: Is More Upside Left?
FrFord Rises 23% in 6 Months: Should You Buy, Sell or Hold the Stock?
FrAbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock
FrCharlotte AI Usage Jumps 85%: Will it Power CRWD's Growth Momentum?
FrLam Research vs. Micron: Which Semiconductor Stock Is the Better Bet?
FrNVIDIA's Data Center Sales Soar 56% in Q2: Can It Keep the Momentum?
FrBMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?
FrIs BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?
FrWalmart Stock Jumps 22% in Six Months: Hold Steady or Take Profits?
FrExact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs